201 related articles for article (PubMed ID: 23857628)
1. Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism.
Laliberté F; Bookhart BK; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
Patient; 2013; 6(3):213-24. PubMed ID: 23857628
[TBL] [Abstract][Full Text] [Related]
2. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
[TBL] [Abstract][Full Text] [Related]
3. Adherence and dosing frequency of common medications for cardiovascular patients.
Bae JP; Dobesh PP; Klepser DG; Anderson JD; Zagar AJ; McCollam PL; Tomlin ME
Am J Manag Care; 2012 Mar; 18(3):139-46. PubMed ID: 22435907
[TBL] [Abstract][Full Text] [Related]
4. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation.
Yu M; Xie J; Fernandez Lando L; Kabul S; Swindle RW
Clin Ther; 2016 Jan; 38(1):149-60. PubMed ID: 26706658
[TBL] [Abstract][Full Text] [Related]
6. Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy.
Langness J; Cook PF; Gill J; Boggs R; Netsanet N
J Manag Care Spec Pharm; 2014 Aug; 20(8):809-14. PubMed ID: 25062074
[TBL] [Abstract][Full Text] [Related]
7. Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μg.
Malmenäs M; Bouchard JR; Langer J
Clin Ther; 2013 Jun; 35(6):795-807. PubMed ID: 23642290
[TBL] [Abstract][Full Text] [Related]
8. Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees.
Patel K; Sudhir VS; Kabadi S; Huang JC; Porwal S; Thakkar K; Pagel JM
J Oncol Pharm Pract; 2019 Dec; 25(8):1897-1906. PubMed ID: 30823852
[TBL] [Abstract][Full Text] [Related]
9. Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily Therapy.
Iglay K; Cao X; Mavros P; Joshi K; Yu S; Tunceli K
Clin Ther; 2015 Aug; 37(8):1813-21.e1. PubMed ID: 26117406
[TBL] [Abstract][Full Text] [Related]
10. Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Bergvall N; Petrilla AA; Karkare SU; Lahoz R; Agashivala N; Pradhan A; Capkun G; Makin C; McGuiness CB; Korn JR
J Med Econ; 2014 Oct; 17(10):696-707. PubMed ID: 25019581
[TBL] [Abstract][Full Text] [Related]
11. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Oladapo AO; Barner JC; Rascati KL; Strassels SA
Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
[TBL] [Abstract][Full Text] [Related]
12. Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.
Slabaugh SL; Bouchard JR; Li Y; Baltz JC; Meah YA; Moretz DC
Adv Ther; 2015 Dec; 32(12):1206-21. PubMed ID: 26563324
[TBL] [Abstract][Full Text] [Related]
13. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis.
Iskedjian M; Einarson TR; MacKeigan LD; Shear N; Addis A; Mittmann N; Ilersich AL
Clin Ther; 2002 Feb; 24(2):302-16. PubMed ID: 11911560
[TBL] [Abstract][Full Text] [Related]
14. Adherence and persistence in patients with type 2 diabetes mellitus newly initiating canagliflozin, dapagliflozin, dpp-4s, or glp-1s in the United States.
Cai J; Divino V; Burudpakdee C
Curr Med Res Opin; 2017 Jul; 33(7):1317-1328. PubMed ID: 28418262
[TBL] [Abstract][Full Text] [Related]
15. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes.
Dezii CM; Kawabata H; Tran M
South Med J; 2002 Jan; 95(1):68-71. PubMed ID: 11827247
[TBL] [Abstract][Full Text] [Related]
16. A novel model-based approach for dose determination of glycopyrronium bromide in COPD.
Arievich H; Overend T; Renard D; Gibbs M; Alagappan V; Looby M; Banerji D
BMC Pulm Med; 2012 Dec; 12():74. PubMed ID: 23217058
[TBL] [Abstract][Full Text] [Related]
17. Adherence to multiple medications prescribed for a chronic disease: a methodological investigation.
Basak R; McCaffrey Iii DJ; Bentley JP; Przybyla SM; West-Strum D; Banahan BF
J Manag Care Spec Pharm; 2014 Aug; 20(8):815-23. PubMed ID: 25062075
[TBL] [Abstract][Full Text] [Related]
18. Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs.
Averell CM; Stanford RH; Laliberté F; Wu JW; Germain G; Duh MS
J Asthma; 2021 Jan; 58(1):102-111. PubMed ID: 31607180
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population.
Nguyen H; Dufour R; Caldwell-Tarr A
Adv Ther; 2017 Mar; 34(3):658-673. PubMed ID: 28078541
[TBL] [Abstract][Full Text] [Related]
20. Impact of number of medications and age on adherence to antihypertensive medications: A nationwide population-based study.
Kim SJ; Kwon OD; Han EB; Lee CM; Oh SW; Joh HK; Oh B; Kwon H; Cho B; Choi HC
Medicine (Baltimore); 2019 Dec; 98(49):e17825. PubMed ID: 31804305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
